Business
Eiko Lifesciences Limited Press Release Feb 26 2026
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Bhavesh Dhirajlal Tanna
About this update from Eiko Lifesciences Limited
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Bhavesh Dhirajlal Tanna View Attachment
View stock analysis, news, and events for Eiko Lifesciences Limited